- Home
- SIG vs INDV Comparison
SIG vs INDV Comparison
Compare SIG & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIG | INDV |
|---|---|---|
| Founded | 1950 | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SIG | INDV |
|---|---|---|
| Price | $88.25 | $30.48 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $111.14 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 3.4M |
| Earning Date | 03-19-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | 974.07 | ★ 8100.00 |
| EPS | ★ 7.08 | 1.64 |
| Revenue | ★ $6,247,100,000.00 | $1,239,000,000.00 |
| Revenue This Year | $2.22 | N/A |
| Revenue Next Year | $1.55 | N/A |
| P/E Ratio | ★ $11.98 | $18.58 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $50.02 | $8.67 |
| 52 Week High | $110.20 | $38.00 |
Technical Indicators
Market Signals| Indicator | SIG | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 49.63 | 46.18 |
| Support Level | $79.54 | $29.71 |
| Resistance Level | $95.10 | $35.75 |
| Average True Range (ATR) | 4.62 | 1.27 |
| MACD | 0.21 | 0.17 |
| Stochastic Oscillator | 64.23 | 59.43 |
Price Performance
Historical ComparisonAbout SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).